Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 43.20 USD | +0.10% |
|
-7.96% | -1.92% |
| Nov. 10 | Scholar Rock Holding Corporation, Q3 2026 Earnings Call, Nov 10, 2026 | |
| Nov. 10 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Amid October Consumer Inflation Report | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.27B | - | - | - | - | - |
| 66.33B | |||||
| 60.62B | |||||
| 55.5B | |||||
| 47.58B | |||||
| 43.69B |
Select your edition
All financial news and data tailored to specific country editions
